First and only FDA-approved fixed-dose, triple-combination topical treatment LAVAL, QC — Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health”) and its dermatology business, Ortho Dermatologics, announced that the U.S. Food… Read More
VANCOUVER, BC — Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), announces it has increased its debt by $1,000,000 to support operating costs and the new sales… Read More
MISSISSAUGA, ON and KIKLAND, QC — Sumitomo Pharma Canada, Inc. and Pfizer Canada announced that Health Canada has granted a Notice of Compliance (NOC) for MYFEMBREE (Relugolix, estradiol and norethindrone… Read More
UBC’s Dr. Catrina Loucks is among the recipients of new funding from the B.C. government for her research aimed at improving pain management for vulnerable B.C. children, including those with cancer and… Read More
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) announced that it will release financial and operational results for the third quarter of 2023, on Thursday, November 2, 2023, before… Read More
